IL136394A0 - Identification and characterization of interacting molecules by automated interaction mating - Google Patents

Identification and characterization of interacting molecules by automated interaction mating

Info

Publication number
IL136394A0
IL136394A0 IL13639498A IL13639498A IL136394A0 IL 136394 A0 IL136394 A0 IL 136394A0 IL 13639498 A IL13639498 A IL 13639498A IL 13639498 A IL13639498 A IL 13639498A IL 136394 A0 IL136394 A0 IL 136394A0
Authority
IL
Israel
Prior art keywords
interacting molecules
identification
characterization
present
automated interaction
Prior art date
Application number
IL13639498A
Other languages
English (en)
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of IL136394A0 publication Critical patent/IL136394A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Vending Machines For Individual Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13639498A 1997-11-27 1998-11-27 Identification and characterization of interacting molecules by automated interaction mating IL136394A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP97120867 1997-11-27
EP97120879 1997-11-27
EP97120880 1997-11-27
PCT/EP1998/007657 WO1999028745A1 (en) 1997-11-27 1998-11-27 Identification and characterization of interacting molecules by automated interaction mating

Publications (1)

Publication Number Publication Date
IL136394A0 true IL136394A0 (en) 2001-06-14

Family

ID=27238345

Family Applications (3)

Application Number Title Priority Date Filing Date
IL13639298A IL136392A0 (en) 1997-11-27 1998-11-27 Improved method for the identification and characterization of interacting molecules using automation
IL13639398A IL136393A0 (en) 1997-11-27 1998-11-27 Identification and characterization of interacting molecules
IL13639498A IL136394A0 (en) 1997-11-27 1998-11-27 Identification and characterization of interacting molecules by automated interaction mating

Family Applications Before (2)

Application Number Title Priority Date Filing Date
IL13639298A IL136392A0 (en) 1997-11-27 1998-11-27 Improved method for the identification and characterization of interacting molecules using automation
IL13639398A IL136393A0 (en) 1997-11-27 1998-11-27 Identification and characterization of interacting molecules

Country Status (10)

Country Link
US (1) US6664048B1 (xx)
EP (3) EP1042670B1 (xx)
JP (3) JP2002507386A (xx)
AT (2) ATE269974T1 (xx)
AU (3) AU1757599A (xx)
CA (3) CA2311705A1 (xx)
DE (2) DE69822510T2 (xx)
GB (1) GB2338711B (xx)
IL (3) IL136392A0 (xx)
WO (3) WO1999028745A1 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029847B2 (en) 2000-05-16 2006-04-18 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
AU2001263155A1 (en) 2000-05-16 2001-11-26 Massachusetts Institute Of Technology Methods and compositions for interaction trap assays
WO2001096597A2 (en) * 2000-06-13 2001-12-20 Glaxo Group Limited High throughput screening of compounds for biological activity
DE60130211T2 (de) * 2000-06-23 2008-05-29 Domantis Ltd., Brentford Matrix-screening-verfahren
JP4024994B2 (ja) 2000-06-30 2007-12-19 株式会社東芝 半導体発光素子
WO2002004628A2 (en) * 2000-07-06 2002-01-17 Genvec, Inc. Method of identifying a binding partner of a gene product
DE50015173D1 (de) 2000-07-13 2008-07-03 Ct Concept Technologie Ag Verfahren und vorrichtung zur zustandsabhängigen regelung des transienten verhaltens von leistungshalbleiterschaltern
US7390458B2 (en) * 2000-10-13 2008-06-24 Irm Llc High throughput processing system and method of using
EP1975620A3 (en) 2001-03-02 2008-12-24 GPC Biotech AG Three hybrid assay system
EP1243327A1 (de) * 2001-03-19 2002-09-25 BioChip Technologies GmbH Oberfläche mit einem Muster aus Zellen und Verfahren zu deren Herstellung
US7219016B2 (en) * 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
WO2002103608A2 (en) * 2001-06-14 2002-12-27 Ramot University Authority For Applied Research & Industrial Development Ltd. Method of expanding a biological network
DE10141522C1 (de) * 2001-08-24 2003-03-06 Siemens Ag Verfahren zur Herstellung einer Leuchtstoffschicht
US20020094519A1 (en) * 2002-03-07 2002-07-18 Agencourt Bioscience Corporation Detection of protein interactions
US20040067532A1 (en) 2002-08-12 2004-04-08 Genetastix Corporation High throughput generation and affinity maturation of humanized antibody
US20050074780A1 (en) * 2003-10-01 2005-04-07 Bryhan Marie D. Device for analyzing slides
WO2006040154A2 (en) * 2004-10-14 2006-04-20 Dublin City University Prokaryotic two hybrid system
US8034180B2 (en) 2005-10-11 2011-10-11 Applied Materials, Inc. Method of cooling a wafer support at a uniform temperature in a capacitively coupled plasma reactor
US7988872B2 (en) 2005-10-11 2011-08-02 Applied Materials, Inc. Method of operating a capacitively coupled plasma reactor with dual temperature control loops
US8157951B2 (en) 2005-10-11 2012-04-17 Applied Materials, Inc. Capacitively coupled plasma reactor having very agile wafer temperature control
US8092638B2 (en) 2005-10-11 2012-01-10 Applied Materials Inc. Capacitively coupled plasma reactor having a cooled/heated wafer support with uniform temperature distribution
US20070091540A1 (en) * 2005-10-20 2007-04-26 Applied Materials, Inc. Method of processing a workpiece in a plasma reactor using multiple zone feed forward thermal control
US7932030B2 (en) * 2007-04-05 2011-04-26 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College System for pulling out regulatory elements using yeast
CA2697193C (en) 2007-09-14 2017-06-06 Adimab, Inc. Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
AU2011279073B2 (en) 2010-07-16 2016-06-09 Adimab, Llc Antibody libraries
WO2018011422A1 (en) * 2016-07-15 2018-01-18 Danmarks Tekniske Universitet Plating cells and corresponding picking colonies
US20210285062A1 (en) * 2017-05-16 2021-09-16 The Regents Of The University Of California Fluorescence detection in yeast colonies
US20210147790A1 (en) * 2019-11-06 2021-05-20 General Automation Lab Technologies Inc. Method for picking biological sample

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5789184A (en) 1993-03-31 1998-08-04 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US5503977A (en) 1994-04-22 1996-04-02 California Institute Of Technology Split ubiquitin protein sensor
EP0830459B1 (en) * 1995-04-11 2007-01-24 The General Hospital Corporation Reverse two-hybrid systems
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
EP0790304A1 (en) * 1995-12-21 1997-08-20 AMERSHAM INTERNATIONAL plc Improvements relating to assay systems
US6083693A (en) * 1996-06-14 2000-07-04 Curagen Corporation Identification and comparison of protein-protein interactions that occur in populations
WO1998007845A1 (en) * 1996-08-23 1998-02-26 President And Fellows Of Harvard College Interaction trap assay, reagents and uses thereof

Also Published As

Publication number Publication date
EP1036329A1 (en) 2000-09-20
WO1999028745A1 (en) 1999-06-10
AU762954B2 (en) 2003-07-10
CA2311927A1 (en) 1999-06-10
ATE269974T1 (de) 2004-07-15
AU2050499A (en) 1999-06-16
GB2338711A (en) 1999-12-29
AU2050599A (en) 1999-06-16
CA2311896A1 (en) 1999-06-24
WO1999031509A1 (en) 1999-06-24
AU760908B2 (en) 2003-05-22
DE69824757T2 (de) 2005-10-20
DE69824757D1 (de) 2004-07-29
JP2002507386A (ja) 2002-03-12
ATE262178T1 (de) 2004-04-15
EP1042670B1 (en) 2004-03-17
EP1036324A1 (en) 2000-09-20
DE69822510D1 (de) 2004-04-22
WO1999028744A1 (en) 1999-06-10
IL136393A0 (en) 2001-06-14
GB2338711A8 (en) 2000-01-26
JP2002508517A (ja) 2002-03-19
GB2338711B (en) 2000-11-15
GB9923293D0 (en) 1999-12-08
EP1036324B1 (en) 2004-06-23
EP1042670A1 (en) 2000-10-11
IL136392A0 (en) 2001-06-14
CA2311705A1 (en) 1999-06-10
AU1757599A (en) 1999-07-05
US6664048B1 (en) 2003-12-16
JP2001525186A (ja) 2001-12-11
DE69822510T2 (de) 2005-03-24

Similar Documents

Publication Publication Date Title
IL136394A0 (en) Identification and characterization of interacting molecules by automated interaction mating
WO1999057311A3 (en) Novel method for the identification of clones conferring a desired biological property from an expression library
AU5794498A (en) Releasable nonvolatile mass-label molecules
DE69719057T2 (de) Verfahren zur signalverstärkung
WO2003036256A3 (en) Method and apparatus for increasing the dynamic range and accuracy of binding assays
DE60030145D1 (de) Nachweisverfahren für kurze sequenzvarianten
EP0892048A3 (en) XAF genes and polypeptides and their use for modulating apoptosis
EP1080227A4 (en) NEW METHOD FOR DIAGNOSING, MONITORING AND STADIFYING COLON CANCER
WO2001038566A3 (en) Screening method for candidate drugs
WO2002033044A3 (en) Methods of high-throughput screening for internalizing antibodies
GR3035495T3 (en) Process and compounds for use in detecting analytes by measurement of residual magnetism, and the use of the said compounds
WO2002058533A3 (en) Process for determining target function and identifying drug leads
CA2129044A1 (en) Determination of binding affinity using magnetically-labeled binding members
EP1188060A4 (en) METHOD AND APPARATUS FOR DISPLAYING DATA RELATING TO ANALYSIS OF THROMBOSIS AND HEMOSTASIS
WO1999041387A3 (en) Prostate-associated serine protease
DE60025380D1 (de) Ein-schritttest zum nachweis von antimikrobiellen rückständen in eiern
EP1268842A4 (en) IMPROVED N HYBRID REVERSE SCREENING METHOD
WO2001040312A3 (en) Naive screening method
WO2002095054A3 (en) Method of determining protein interaction inhibitors
WO1997019178A3 (de) Autoantigene Metallproteasen und Verfahren zur Diagnose von Autoimmunkrankheiten
Simandl et al. MAGNESITE DEPOSITS OF BRITISH COLUMBIA- DEVELOPMENT POTENTIAL
ZA965458B (en) Novel detection methods for cryptosporidium
WO2002042467A8 (en) Aspergillus fumigatus profilin
WO2002083941A3 (de) Hochspezifisches detektionssystem für den nachweis von lambda- und kappa- leichte ketten codierenden nukleotidsequenzen
DK0970249T3 (da) Fremgangsmåde til detektion af muterede alleler